儿童慢性咳嗽管理算法在急性向慢性过渡阶段的有效性:多中心嵌套单盲随机对照试验
该研究在澳大利亚开展多中心、单盲、嵌套于前瞻性队列的随机对照试验,纳入因急性呼吸道疾病伴咳嗽就诊的<15岁儿童,对第28天仍有持续咳嗽者随机分配至咳嗽管理算法组或常规护理组。结果显示第56天干预组咳嗽缓解率58%(33/57),对照组40%(23/58);结论提示循证咳嗽管理算法可改善社区儿童慢性咳嗽早期阶段的咳嗽缓解,但需更大规模研究在初级保健中验证。
要点
- 对第28天仍有持续咳嗽的儿童,应用循证咳嗽管理算法可提高第56天咳嗽缓解率。
- 需治疗人数为5(95%CI 3-364),但研究样本量有限,需更大规模验证。
核心结论
- 该研究提示循证咳嗽管理算法可改善社区儿童慢性咳嗽早期阶段的咳嗽缓解,但需更大规模研究在初级保健中确认。
研究设计与样本
- 多中心、单盲、随机对照试验,嵌套于前瞻性队列研究,在澳大利亚三个初级保健或三个医院急诊科开展。
- 纳入<15岁因急性呼吸道疾病伴咳嗽就诊的儿童,排除已知慢性基础疾病(除外哮喘)、免疫抑制疾病或近30天使用免疫调节药物>2周、或需住院的重症症状者。
- 随访8周,第28天仍有持续咳嗽者按1:1随机分配至咳嗽管理算法组或常规护理组,随机化按就诊原因、研究地点和咳嗽持续时间(4周至<6周 vs ≥6周)分层,采用计算机生成区组大小为4的置换区组。
- 主要结局为第56天咳嗽缓解比例,定义为自第28天起至少3天3夜无咳嗽或平均日间和夜间咳嗽评分较第28天降低>75%。
- 采用改良意向性分析(ITT)计算绝对风险差(RDabsolute)。
主要发现
- 2015年7月7日至2018年10月31日筛查1018名儿童,509名入组队列研究,115名进入ITT分析,干预组57名、对照组58名。
- 第56天干预组33名(58%)达到咳嗽缓解,对照组23名(40%);干预组12名(21%)、对照组13名(22%)咳嗽结局未知。
关键数值与推荐
- 慢性咳嗽定义为持续至少4周。
- 咳嗽缓解定义为自第28天起至少3天3夜无咳嗽或平均日间和夜间咳嗽评分较第28天降低>75%。
- 主要结局为第56天咳嗽缓解比例。
临床怎么用
- 对于急性呼吸道疾病后咳嗽持续超过4周的社区儿童,可考虑应用循证咳嗽管理算法以促进咳嗽缓解。
- 该算法在非专科环境中早期应用可能改善咳嗽结局,但需结合临床判断并注意研究人群特征。
局限性
- 样本量有限(ITT分析115名儿童),需更大规模研究在初级保健中确认。
- 部分儿童咳嗽结局未知(干预组21%,对照组22%),分析时假设其仍在咳嗽。
- 研究在澳大利亚特定人群中进行,外推性需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic (lasting at least 4 weeks) cough in children is an important cause of morbidity. An algorithmic approach to the management of coughs in children evaluated in observational studies and a randomised controlled trial (RCT) enrolled children referred with median cough duration of 16 weeks to specialist centres. We investigated whether applying an evidence-based cough management algorithm in non-specialist settings earlier, once cough persisted for more than 4 weeks, improved cough resolution compared with usual care. METHODS: We undertook a multicentre, single-blind RCT nested within a prospective cohort study of children (<15 years) in Australia presenting to three primary care or three hospital emergency departments with an acute respiratory illness with cough. Children were excluded if they had a known diagnosis of an underlying chronic medical condition (excluding asthma) or had an immunosuppressive illness or were taking immunomodulating drugs for more than 2 weeks in the preceding 30 days, or had severe symptoms requiring inpatient hospitalisation. Children were followed up for 8 weeks; those with a persistent cough at day 28 were randomly assigned to the cough management algorithm or to usual care. Randomisation was stratified by reason for presentation, study site, and cough duration (4 weeks to <6 weeks vs ≥6 weeks) using computer-generated permuted blocks (block size of four) with a 1:1 allocation. The primary outcome was the proportion of children with cough resolution at day 56 (defined as resolved if the child did not cough for at least 3 days and nights since day 28 or a more than 75% reduction in their average day and night cough score). Absolute risk differences (RDabsolute) were calculated by modified intention-to-treat analysis (ITT). This trial is registered with the Australia New Zealand Clinical Trials Registry, ACTRN12615000132549. FINDINGS: Between July 7, 2015, and Oct 31, 2018, 1018 children were screened, 509 were enrolled in the cohort study, and of 115 children in the ITT analysis, 57 were randomly assigned to the intervention group and 58 to the control group. Children had a median age of 1·6 years (IQR 1·0-4·5); 45 (39%) of 115 were Indigenous, and 59 (51%) were boys. By day 56, 33 (58%) of 57 children in the intervention group achieved cough resolution compared with 23 (40%) 58 in the control group; cough resolution was unknown in 12 (21%) of 57 children receiving the intervention and in 13 (22%) of 58 receiving the control. The RDabsolute assuming children with an unknown cough outcome were still coughing at day 56 was 18·3% (95% CI 0·3-36·2); the number needed-to-treat for benefit was five (95% CI 3-364); the adjusted odds ratio was 1·5 (95% CI 1·3-1·6), favouring the intervention group. INTERPRETATION: This study suggests an evidence-based cough management algorithm improves cough resolution in community-based children in the early phases of chronic cough. However, larger studies to confirm these findings in primary care are required. FUNDING: National Health and Medical Research Council.
引用
- O'Grady KF, Grimwood K, Torzillo PJ, et al. Effectiveness of a chronic cough management algorithm at the transitional stage from acute to chronic cough in children: a multicenter, nested, single-blind, randomised controlled trial. Lancet Child Adolesc Health. 2019. PMID: 31635952. doi:10.1016/S2352-4642(19)30327-X
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。